Market Announcement 16 November 2026 Genetic Signatures Limited (ASX: GSS) – Trading Halt Trading in the securities of Genetic Signatures Limited (‘GSS’) will be halted at the request of GSS, pending the release of an announcement by GSS. Unless ASX decides otherwise, the securities will...
Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Genetic Signatures Ltd. has requested a trading halt for its securities on the Australian Securities Exchange pending an announcement regarding a proposed merger. The halt is intended to assist the company in managing its continuous disclosure obligations as it prepares to inform the market about material changes to the merger terms. The trading halt will remain in effect until the earlier of the announcement's release or the commencement of normal trading on a specified date.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-2148
Release
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- GSS - Panel Receives Application
- Postponement of AGM & Further Addendum to the Notice of AGM
- Notification regarding unquoted securities - GSS
- 3X Initial Directors Interest Notice
- BCAL Welcomes Dr John Melki's Appointment to GSS Board
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures